Different eukaryotic initiation factor 2Bε mutations lead to various degrees of intolerance to the stress of endoplasmic reticulum in oligodendrocytes

Chinese Medical Journal

Volumn 128, Issue 13, 2015, Pages 1772-1777

  Chen, Na ^a   Jiang, Yu Wu ^a   Hao, Hong Jun ^a   Ban, Ting Ting ^a   Gao, Kai ^a   Zhang, Zhong Bin ^a   Wang, Jing Min ^a   Wu, Ye ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Autophagy flux; EIF2B5 (Eukaryotic Initiation Factor 2B ); Endoplasmic reticulum stress; Unfolded protein response; Vanishing white matter disease

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GUANINE NUCLEOTIDE EXCHANGE FACTOR;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DELETION MUTANT; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; LIGHT CHAIN; MISSENSE MUTATION; OLIGODENDROGLIA; PROTEIN EXPRESSION; WESTERN BLOTTING; CELL LINE; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; UNFOLDED PROTEIN RESPONSE;

CELL LINE; ENDOPLASMIC RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2B; HUMANS; MUTATION; OLIGODENDROGLIA; UNFOLDED PROTEIN RESPONSE;

EID: 84933499404     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.159353     Document Type: Article

References (29)

1. van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol 2006;5:413-23.
2. Leegwater PA, Vermeulen G, Könst AA, Naidu S, Mulders J, Visser A, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 2001;29:383-8.
3. Kimball SR, Mellor H, Flowers KM, Jefferson LS. Role of translation initiation factor eIF-2B in the regulation of protein synthesis in mammalian cells. Prog Nucleic Acid Res Mol Biol 1996;54:165-96.
4. Webb BL, Proud CG. Eukaryotic initiation factor 2B (eIF2B). Int J Biochem Cell Biol 1997;29:1127-31.
5. Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, et al. Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol 2008;23:205-15.
6. van der Lei HD, van Berkel CG, van Wieringen WN, Brenner C, Feigenbaum A, Mercimek-Mahmutoglu S, et al. Genotype-phenotype correlation in vanishing white matter disease. Neurology 2010;75:1555-9.
7. Li W, Wang X, Van Der Knaap MS, Proud CG. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol Cell Biol 2004;24:3295-306.
8. van der Voorn JP, van Kollenburg B, Bertrand G, Van Haren K, Scheper GC, Powers JM, et al. The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol 2005;64:770-5.
9. van Kollenburg B, van Dijk J, Garbern J, Thomas AA, Scheper GC, Powers JM, et al. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol 2006;65:707-15.
10. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012;8:445-544.
11. Richardson JP, Mohammad SS, Pavitt GD. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity. Mol Cell Biol 2004;24:2352-63.
12. Larocca JN, Rodriguez-Gabin AG. Myelin biogenesis: Vesicle transport in oligodendrocytes. Neurochem Res 2002;27:1313-29.
13. Van Haren K, van der Voorn JP, Peterson DR, van der Knaap MS, Powers JM. The life and death of oligodendrocytes in vanishing white matter disease. J Neuropathol Exp Neurol 2004;63:618-30.
14. Bugiani M, Boor I, van Kollenburg B, Postma N, Polder E, van Berkel C, et al. Defective glial maturation in vanishing white matter disease. J Neuropathol Exp Neurol 2011;70:69-82.
15. Bugiani M, Postma N, Polder E, Dieleman N, Scheffer PG, Sim FJ, et al. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. Brain 2013;136:209-22.
16. Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 2004;62:1509-17.
17. Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans 2006;34:22-9.
18. Horzinski L, Gonthier C, Rodriguez D, Scherer C, Boespflug-Tanguy O, Fogli A. Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity. Ann Hum Genet 2008;72:410-5.
19. Leng X, Wu Y, Wang X, Pan Y, Wang J, Li J, et al. Functional analysis of recently identified mutations in eukaryotic translation initiation factor 2Bɛ (eIF2Bɛ) identified in Chinese patients with vanishing white matter disease. J Hum Genet 2011;56:300-5.
20. Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, et al. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet 2004;12:561-6.
21. Kantor L, Harding HP, Ron D, Schiffmann R, Kaneski CR, Kimball SR, et al. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients. Hum Genet 2005;118:99-106.
22. Horzinski L, Kantor L, Huyghe A, Schiffmann R, Elroy-Stein O, Boespflug-Tanguy O, et al. Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients. BMC Neurol 2010;10:94.
23. Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-89.
24. Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta 2013;1833:3460-70.
25. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, et al. Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer’s disease. J Neurosci 2008;28:6926-37.
26. Hochfeld WE, Lee S, Rubinsztein DC. Therapeutic induction of autophagy to modulate neurodegenerative disease progression. Acta Pharmacol Sin 2013;34:600-4.
27. Matus S, Glimcher LH, Hetz C. Protein folding stress in neurodegenerative diseases: A glimpse into the ER. Curr Opin Cell Biol 2011;23:239-52.
28. Schwarz L, Goldbaum O, Bergmann M, Probst-Cousin S, Richter-Landsberg C. Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci 2012;47:256-66.
29. Glick D, Barth S, Macleod KF. Autophagy: Cellular and molecular mechanisms. J Pathol 2010;221:3-12.